Craft
Bruker

Bruker

Backlog

$2 B

FY, 2020

Revenue

$2.4 B

FY, 2021

Market Capitalization

$7.4 B

2022-09-27

Bruker Summary

Company summary

Overview
Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. It has four operating segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Segment, and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment offers life science mass spectrometry (MS) instruments that can be integrated and used along with sample preparation or chromatography instruments to design an analytical workflow and mass spectrometry-based and molecular diagnostic solutions for microbiology and infectious disease diagnostics. The BSI Nano Segment provides X-ray instruments, analytical tools for electron microscopes, and atomic force microscopy instrumentation. The BEST Segment offers superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications.
Type
Public
Founded
1960
HQ
Billerica, MA, US | view all locations
Website
https://www.bruker.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Frank H. Laukien

    Frank H. Laukien, Chairman, President and Chief Executive Officer

  • Gerald N. Herman

    Gerald N. Herman, Executive Vice President & Chief Financial Officer

    • Mark R. Munch

      Mark R. Munch, President of Bruker Nano Group and Corporate Executive Vice President

    • Juergen Srega

      Juergen Srega, President, Bruker CALID Group and Bruker Daltonics Division

      Operating MetricsView all

      Backlog

      $2B
      8.2%

      FY, 2020

      LocationsView all

      54 locations detected

      • Billerica, MA HQ

        United States

        40 Manning Rd

      • Billerica, MA

        United States

        15 Fortune Dr

      • Carteret, NJ

        United States

        600 Milik St

      • Preston, VIC

        Australia

        1a/28 Albert St

      • Wien, Wien

        Austria

        Lemböckgasse 47B

      • Kontich, Vlaanderen

        Belgium

        Kartuizersweg 3

      and 48 others

      Bruker Financials

      Summary financials

      Revenue (Q2, 2022)
      $588.4M
      Gross profit (Q2, 2022)
      $298.2M
      Net income (Q2, 2022)
      $49.7M
      Cash (Q2, 2022)
      $723.0M
      EBIT (Q2, 2022)
      $73.9M
      Enterprise value
      $7.9B

      Footer menu